Theranos’ blood testing technology was supposed to completely revolutionize healthcare. It was a portable blood analyzer, known as the Edison, that could perform a range of tests on a small finger-prick of blood. Investors pumped millions of dollars into the company, spellbound by founder Elizabeth Holmes and her promises of
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day